Are insulin attitudes related to glycaemic control? v 1.2
Research type
Research Study
Full title
The relationship between insulin attitudes and glycaemic control in people with type 2 diabetes
IRAS ID
222809
Contact name
Lauren Kilbee
Contact email
Sponsor organisation
University of Stirling
Duration of Study in the UK
0 years, 1 months, 14 days
Research summary
The primary purpose of this research is to investigate the relationship between insulin attitudes and glycaemic control in people with type 2 diabetes. A secondary objective is to investigate the demographic and clinical factors that may influence insulin attitudes. Previous research has shown that negative attitudes towards insulin exist even in people who have been on insulin for some time. Negative attitudes towards insulin have been linked with poorer emotional well-being and greater diabetes distress, but there has been little work looking at whether such attitudes are related to key clinical outcomes such a HbA1c (glycated haemoglobin, the objective test of glycaemic control).
People with type 2 diabetes, aged >18 and <75 years, prescribed any form of insulin therapy will be eligible to take part in this study. Participants will be patients attending routine clinics in the outpatient Diabetes Centres at Ayr Hospital (NHS Ayrshire & Arran) and Hairmyres Hospital (NHS Lanarkshire).
The study is being undertaken as MSc Health Psychology research. Data will be collected over a period of 1 month. Participants will be asked to complete a questionnaire when they attend their review appointment. This will consist of 4 questions on demographic/clinical information and the Insulin Treatment Appraisal Scale (ITAS) questionnaire (20 items). The patients’ most recent HbAc1c readings will be obtained for use in the analysis. Information on participants’ duration of diabetes, Body Mass Index, presence or absence of Retinopathy, Neuropathy and Nephropathy, and a list of all current prescribed diabetes medications will also be obtained from medical records by the direct clinical care team. Collecting this information will help us to understand the characteristics of the sample population in terms of the presence of any diabetes-related complications. Participant involvement is estimated to be a maximum of 10 minutes from consent to completion.
REC name
Yorkshire & The Humber - Sheffield Research Ethics Committee
REC reference
17/YH/0162
Date of REC Opinion
11 May 2017
REC opinion
Favourable Opinion